Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma
Academic Article
Publication Date:
2022
Short description:
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma / Basile, G., Rosiello, G., Larcher, A., Fallara, G., Martini, A., Re, C., Cignoli, D., Tian, Z., Karakiewicz, P.I., Mottrie, A., Bertini, R., Necchi, A., Raggi, D., Salonia, A., Briganti, A., Montorsi, F., Capitanio, U.. - In: UROLOGIC ONCOLOGY. - ISSN 1078-1439. - 40:8(2022), pp. 384-384.e21. [Epub ahead of print] [10.1016/j.urolonc.2022.05.012]
abstract:
Despite papillary renal cell carcinoma (pRCC) subtype represents the second most common histological renal tumor, controversial findings have been shown regarding its prognosis. Thus, we investigated the natural history of patients harbouring pRCC, focusing on its clinicopathological characteristics and long-term oncologic outcomes among pRCC subtypes.
Iris type:
1.1 Articolo in rivista
List of contributors:
Basile, Giuseppe; Rosiello, Giuseppe; Larcher, Alessandro; Fallara, Giuseppe; Martini, Alberto; Re, Chiara; Cignoli, Daniele; Tian, Zhe; Karakiewicz, Pierre I; Mottrie, Alexandre; Bertini, Roberto; Necchi, Andrea; Raggi, Daniele; Salonia, Andrea; Briganti, Alberto; Montorsi, Francesco; Capitanio, Umberto
Published in: